Fine particulate matter exposure exacerbated nasal mucosal damage in allergic rhinitis mice via NLRP3 mediated pyroptosis

被引:25
|
作者
Li, Juan [1 ]
Zhang, Ying [1 ]
Zhang, Lin [2 ]
An, Zhen [1 ]
Song, Jie [1 ]
Wang, Chunzhi [1 ]
Ma, Yanmei [1 ]
Gu, Qi [1 ]
Luo, Qizhan [1 ]
Yang, Weiling [1 ]
Du, Yue [1 ]
Wu, Weidong [1 ]
机构
[1] Xinxiang Med Univ, Sch Publ Hlth, Int Collaborat Lab Air Pollut Hlth Effects & Inte, Xinxiang 453003, Henan, Peoples R China
[2] Shandong Univ, Maternal & Child Hlth Care Hosp Shandong Prov, Key Lab Birth Regulat & Control Technol Natl Hlth, Jinan 250001, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
PM2.5; Allergic rhinitis; Nasal mucosa; NLRP3; Pyroptosis; AIR-POLLUTION; ASTHMA; PREVALENCE; PM10; CHILDREN; OUTDOOR; CITIES; IMPACT; PM2.5;
D O I
10.1016/j.ecoenv.2021.112998
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: The incidence of nasal allergy/allergic rhinitis (AR) is rising worldwide, which has become a serious public health problem. Epidemiological studies point that exposure to environmental PM2.5 is closely linked to AR aggravation, however, the exactly mechanism is not clear. This study was performed to reveal molecular mechanisms of PM2.5 -induced AR deterioration. Methods: Morphology and element analysis of PM2.5 was examined by scanning electron microscopy (SEM) and Energy Dispersive Spectrometer (EDS). A total of 24 female C57BL/6 mice were divided into three groups (control group, AR group, and PM2.5 + AR group, each group contains 8 mice). Mice from AR group and PM2.5 + AR group were intraperitoneally injected with OVA suspension (0.004% OVA+3% aluminum hydroxide) on days 1, 7, and 14. 0.2 mL /kg B.W. for sensitization; then the same mice were intranasal instilled with 5% OVA solution daily for 7 days to established AR mice model (each nostril for 10 mu l, day 15-21). The mice were intranasal instilled PBS (control group and AR group, each nostril for 10 mu l) or PM2.5 (AR + PM2.5 group, 4.0 mg/kg b.w., each nostril for 10 mu l) at the same way from day 23-29. The nasal symptoms were evaluated after the last instillation of PM2.5. Pathological changes and ultrastructure of nasal mucosa were observed by HE staining and SEM. Goblet cells hyperplasia was performed by Periodic acid-Schiff (PAS) staining. NLRP3, Caspase-1, GSDMD and IL-1I3 protein expression were assessed by immunohistochemical (IHC) staining. Results: Exposure to PM2.5 aggravated rhinitis symptom, promoted the secretion of serum IgE level and destroyed ultrastructural of nasal mucosa. Interestingly, NLRP3, Caspase-1 GSDMD and IL-1I3 protein expression were obviously elevated. NLRP3 /Capase-1/ GSDMD meditated cell pyroptosis participated in the process of AR exacerbation. However, macrophage is not the main effector cell. Conclusion: PM2.5 exposure induces aggravation of allergic rhinitis, which is related to NLRP3 inflammasome meditated caspase-1 activation and cell pyroptosis in nasal mucosal.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Skin damage induced by zinc oxide nanoparticles combined with UVB is mediated by activating cell pyroptosis via the NLRP3 inflammasome–autophagy–exosomal pathway
    Yu-Ying Chen
    Yu-Hsuan Lee
    Bour-Jr Wang
    Rong-Jane Chen
    Ying-Jan Wang
    Particle and Fibre Toxicology, 19
  • [32] Icariin inhibition of NLRP3 mediated Leydig cell pyroptosis and insulin resistance ameliorates spermatogenesis disorders in obese mice
    Wei, Yanhong
    Tu, Jian
    Ji, Lin
    Wang, Rutong
    Zhou, Runtang
    Lei, Xiaocan
    Hu, Linlin
    Huang, Hua
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 151
  • [33] Farrerol alleviates cognitive impairments in chronic cerebral hypoperfusion via suppressing NLRP3 inflammasome-mediated pyroptosis
    Zhang, Jie
    Zhang, Yaxuan
    Zhang, Yueqi
    Lu, Kaili
    Zhang, Xiaojie
    Wang, Xiuzhe
    Fu, Jianliang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 153
  • [34] Fudosteine attenuates acute lung injury in septic mice by inhibiting pyroptosis via the TXNIP/NLRP3/GSDMD pathway
    He, Guangming
    Chen, Keling
    Wang, Hao
    Li, Xiaoou
    Li, Wenhao
    Liu, Lian
    Chen, Jun
    Yang, Deqing
    Hu, Jun
    Xu, Dan
    Wen, Fuqiang
    Wang, Tao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 926
  • [35] Targeting a novel hsa_circ_0000520/miR-556-5p/NLRP3 pathway-mediated cell pyroptosis and inflammation attenuates ovalbumin (OVA)-induced allergic rhinitis (AR) in mice models
    Yu, Xiaofeng
    Wang, Meng
    Zhao, He
    Cao, Zhiwei
    INFLAMMATION RESEARCH, 2021, 70 (06) : 719 - 729
  • [36] Skin damage induced by zinc oxide nanoparticles combined with UVB is mediated by activating cell pyroptosis via the NLRP3 inflammasome-autophagy-exosomal pathway
    Chen, Yu-Ying
    Lee, Yu-Hsuan
    Wang, Bour-, Jr.
    Chen, Rong-Jane
    Wang, Ying-Jan
    PARTICLE AND FIBRE TOXICOLOGY, 2022, 19 (01)
  • [37] Targeting a novel hsa_circ_0000520/miR-556-5p/NLRP3 pathway-mediated cell pyroptosis and inflammation attenuates ovalbumin (OVA)-induced allergic rhinitis (AR) in mice models
    Xiaofeng Yu
    Meng Wang
    He Zhao
    Zhiwei Cao
    Inflammation Research, 2021, 70 : 719 - 729
  • [38] Astragaloside IV alleviates PM2.5-caused lung toxicity by inhibiting inflammasome-mediated pyroptosis via NLRP3/caspase-1 axis inhibition in mice
    Huang, Demei
    Shi, Shihua
    Wang, Yilan
    Wang, Xiaomin
    Shen, Zherui
    Wang, Mingjie
    Pei, Caixia
    Wu, Yongcan
    He, Yacong
    Wang, Zhenxing
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 150
  • [39] Long non-coding RNA NEAT1 exacerbates NLRP3-mediated pyroptosis in allergic rhinitis through regulating the PTBP1/FOXP1 cascade
    Liu, Yunliang
    Gao, Jing
    Xu, Qingqing
    Zhong, Wenhui
    Wu, Fengfang
    Lin, Xianghang
    Zhang, Qiuyun
    Ye, Qing
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 137
  • [40] Salidroside promotes liver regeneration after partial hepatectomy in mice by modulating NLRP3 inflammasome-mediated pyroptosis pathway
    Zhang, Saiya
    Yu, Meilu
    Wang, Fen
    Li, Sha
    Li, Xuefei
    Hu, Hongyu
    Zhang, Zhen
    Zhu, Xiangpeng
    Tian, Weiqian
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 735